These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 18472237)
1. p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma. Oridate N; Homma A; Higuchi E; Suzuki F; Hatakeyama H; Mizumachi T; Furusawa J; Taki S; Furuta Y; Fukuda S Auris Nasus Larynx; 2009 Feb; 36(1):57-63. PubMed ID: 18472237 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Higuchi E; Oridate N; Homma A; Suzuki F; Atago Y; Nagahashi T; Furuta Y; Fukuda S Head Neck; 2007 Oct; 29(10):940-7. PubMed ID: 17563903 [TBL] [Abstract][Full Text] [Related]
3. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Lavertu P; Adelstein DJ; Myles J; Secic M Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215 [TBL] [Abstract][Full Text] [Related]
5. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy. Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330 [TBL] [Abstract][Full Text] [Related]
8. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck. Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484 [TBL] [Abstract][Full Text] [Related]
9. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Kovács AF; Mose S; Böttcher HD; Bitter K Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas. Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas. Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432 [TBL] [Abstract][Full Text] [Related]
12. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346 [TBL] [Abstract][Full Text] [Related]
14. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy. Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G Anticancer Res; 1998; 18(6B):4685-92. PubMed ID: 9891541 [TBL] [Abstract][Full Text] [Related]
15. beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial. Cullen KJ; Schumaker L; Nikitakis N; Goloubeva O; Tan M; Sarlis NJ; Haddad RI; Posner MR J Clin Oncol; 2009 Dec; 27(36):6222-8. PubMed ID: 19917838 [TBL] [Abstract][Full Text] [Related]
16. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck. Fouret P; Temam S; Charlotte F; Lacau-St-Guily J Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma. Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer. Sauter ER; Ridge JA; Litwin S; Langer CJ Clin Cancer Res; 1995 Nov; 1(11):1407-12. PubMed ID: 9815938 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma. Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]